Clinical trial Recruiting at 1 site Observational Ages 18 to 110

Healing ALS Registry (HAROS) for people with ALS, MND, and PLS

Official title: Healing ALS Registry Observational Study (HAROS)

Run by Healing Advocates Registry and Ministry · NCT07233148 · Data updated 2026-11-12

This fully remote registry asks people with ALS, MND, or PLS to enter monthly health, treatment, and lifestyle information to try to see which therapies and education relate to better physical outcomes.

More Amyotrophic Lateral Sclerosis (ALS) trials

Quick facts

Study typeObservational
Ages18 Years to 110 Years
SexAll
Enrollment1000 (estimated)
SponsorHealing Advocates Registry and Ministry
Academic / other
Locations1 site (Park City, Utah)
StatusRecruiting
StartedJanuary 26, 2026
Main results expectedFebruary 5, 2036
Study endsMarch 31, 2036
Registry record updatedJune 24, 2026
Trial IDNCT07233148 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Adults diagnosed with ALS, MND, or PLS (preferably neurologist-confirmed) who can reliably complete monthly online data entry and are willing to report treatments and outcomes; active smokers are excluded.

Probably not a fit

People who smoke, cannot complete regular online entries, or are seeking access to experimental drug treatments are unlikely to receive direct benefit from this observational registry.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

HAROS is a prospective, fully remote observational registry enrolling at least 1,000 people diagnosed with ALS, MND, or PLS who will complete monthly online entries including ALSFRS‑R scores, symptoms, medications, supplements, diets, therapies, and hours of self‑study or education. The study will correlate these longitudinal patient-reported data with physical outcomes to identify patterns linked with slower progression or improved function. Investigators will analyze conventional and integrative medicine approaches and educational engagement to explore associations with clinical trajectories. Data will be contributed by participants in the U.S. and other countries and analyzed to generate hypotheses for future controlled research.

Why it matters

Potential benefit: If successful, the registry could highlight treatments, behaviors, or education programs associated with better function or slower progression and inform care choices and future trials.

How similar studies have gone: A small 45-patient retrospective registry analysis reported better-than-predicted outcomes, but large prospective evidence supporting integrative approaches in ALS is still limited.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion Criteria:

* Diagnosed with ALS, MND or PLS

Exclusion Criteria:

* Smokers

Where it's running

  • Virtual
    Park City, Utah, United States
    Recruiting

Study contacts

  • Principal investigator: William L Cowden, MD — Chair of Scientific Board of Academy of Comprehensive Integrative Medicine, Co-chair of Medical Advisory Team of Healing ALS
  • Study coordinator: Healing ALS Study Administrator
  • Email: Study@HealingALS.org
  • Phone: 1-973-714-4621

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.